Table 3.
Model 1 | Model 2 | |||
---|---|---|---|---|
SHR (95%CI) | p value | SHR 95% (CI) | p value | |
T, nmol/l | 1.01 (0.91, 1.12) | 0.827 | 1.00 (0.90, 1.12) | 0.939 |
cFT, pmol/l | 1.04 (0.94, 1.15) | 0.480 | 1.02 (0.92, 1.14) | 0.701 |
DHT, nmol/l | 1.05 (0.95, 1.15) | 0.343 | 1.05 (0.95, 1.16) | 0.308 |
E2, pmol/l | 1.04 (0.94, 1.15) | 0.460 | 1.04 (0.94, 1.16) | 0.438 |
Log LH, IU/l | 0.90 (0.81, 1.00) | 0.051 | 0.91 (0.92, 1.02) | 0.101 |
SHBG, nmol/l | 0.96 (0.87, 1.07) | 0.501 | 0.98 (0.88, 1.09) | 0.698 |
Estimates represent subhazard ratios and 95% CIs for each SD increase in hormone level. Model 1 includes adjustments for age, BMI and smoking status. Model 2 includes adjustments for age, BMI, smoking status, physical activity, alcohol, diabetes, HDL, TG and history of prevalent cancer